by October Gallery
FILE PHOTO: Ehud Barak, chairman of InterCure, a holding company of small medical firms, that bought medical cannabis developer Canndoc, speaks during an interview with Reuters in Tel Aviv, Israel…
FRANKFURT/ZURICH (Reuters) – Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an…
(This December 12 story corrects to Missouri from Montana in last paragraph) By Caroline Humer and Julie Steenhuysen NEW YORK (Reuters) – CVS Health Corp said on Thursday it will…
FILE PHOTO: Several Boeing 777X aircraft are seen in various stages of production during a media tour of the Boeing 777X at the Boeing production facility in Everett, Washington, U.S.,…
(Reuters) – In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a “Lazarus effect” in some patients because it can reverse late-stage cancer that…
(Reuters) – The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp’s Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use,…
(Reuters) – Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at…
GENEVA/ZURICH (Reuters) – Immunotherapies that have emerged as a breakthrough in treating lung cancer have been rejected for inclusion on the World Health Organization’s list of “essential medicines”, which received…
SAO PAULO (Reuters) – After an unusual number of explosions, several Brazilian power transmission companies have started removing a piece of equipment made by General Electric Co (GE.N), a blow…
(Reuters) – The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp’s recall of some of its heart devices. The agency…